@rfrosencrans
Reductions in cerebrospinal fluid (brain juice) somatostatin have been documented in many diseases, including depression, Alzheimer's, Parkinson's, and schizophrenia. We extend these finding to diabetes. https://t.co/IF0MhGNT6E
@BrainBankSG
Reduced SST expression is a recognized feature of brain disorders including Alzheimer’s disease. Stable SST analogues and safe delivery methods could broaden treatment options for multiple brain conditions. https://t.co/emky1DTGcj
The role of neuropeptide somatostatin in the brain and its application in treating neurological disorders https://t.co/tT2IiQlhjc https://t.co/I9mmJlJCto
Can one target somatostatin therapeutics to effectively and safely improve neurological disorders? Difficult https://t.co/qV3AS6CnP2